🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:
ВВЕРХ
#PRTK +42% Paratek Pharmaceuticals, Inc. - the Department of Human Health, Office of the Assistant Secretary for Preparedness and Response, and Biomedical Advanced Research and Development Authority, has awarded it a five-year contract, with an option to extend it to 10 years, to support the development of its Nuzyra for the treatment of pulmonary anthrax.
#RAD +22% Rite Aid Corporation - reported better-than-expected Q3 EPS and sales results. The company also issued FY20 EPS guidance above analyst estimates.
#INO +12% Inovio Pharmaceuticals, Inc. -Roth Capital initiated coverage on Inovio Pharmaceuticals with a Buy rating and a $13 price target.
#MOSC +10% Mosaic Acquisition Corp. - Vivint Smart Home and Mosaic Acquisition announced revised transaction terms.
#SNDL +8% Sundial Growers Inc. - after falling 10% on Wednesday. Sundial Growers reported an initiative to enter Canadian medical cannabis business.
#CAG +8% Conagra Brands, Inc. -after the company reported upbeat earnings for its second quarter.
#PING +7% Ping Identity Holding Corp.
#AXSM +7% Axsome Therapeutics, Inc. - priced its 2 million share offering at $87 per share.
#SGEN +6% Seattle Genetics, Inc. - Seattle Genetics and Astellas Pharma said the FDA has granted accelerated approval for Padcev for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a PD-1/L1 inhibitor and a platinum-containing chemotherapy before or after surgery or in a locally advanced or metastatic setting.
#I +5% Intelsat S.A. - after gaining 8% on Wednesday.
#OBSV +5% ObsEva SA
#RUBI +5% the Rubicon Project, Inc. -Rubicon Project and Telaria reported an all stock merger.
#MTCH +4% Match Group, Inc. - announced an agreement with IAC to separate itself from the remaining businesses of IAC.
#MU +4% Micron Technology, Inc.- reported better-than-expected Q1 sales results.
#QIWI +3% Qiwi plc - after dropping 11% on Wednesday.
#AGS +3% PlayAGS, Inc.
#REVG +3% Rev Group Inc - reported better-than-expected Q4 sales results. The company also issued FY20 sales guidance above analyst estimates.
ВНИЗ
#NERV -24% Minerva Neurosciences, Inc. -said the Phase 2b study that evaluated MIN-117 in adult patients with moderate to severe major depressive disorder, or MDD, failed to meet its primary and key secondary endpoints. The company said it has no plans for further clinical development of the molecule in MDD.
#APOG -15% Apogee Enterprises, Inc. - reported worse-than-expected Q3 EPS and sales results. The company also cut FY20 EPS guidance below analyst estimates.
#KODK -14% Eastman Kodak Company -after surging 12% on Wednesday.
#MLHR Herman Miller, Inc. - after the company reported worse-than-expected Q2 sales results. The company also issued Q3 EPS guidance below analyst estimates.
#ASLN -7% ASLAN Pharmaceuticals Limited - after gaining 10% on Wednesday.
#AKRX -6% Akorn, Inc. - after declining 27% on Wednesday.
#XCUR -5% Exicure, Inc. - reported a common stock offering with no size disclosed.
#NIHD -5% NII Holdings, Inc.
#BNTX -5% BioNTech SE -after dropping 5% on Wednesday.
#DRI -4% Darden Restaurants, Inc. - reported second-quarter earnings results.
#YCBD -3% cbdMD, Inc. - reported Q4 results.
премаркет США - акции - заметные движения:
ВВЕРХ
#PRTK +42% Paratek Pharmaceuticals, Inc. - the Department of Human Health, Office of the Assistant Secretary for Preparedness and Response, and Biomedical Advanced Research and Development Authority, has awarded it a five-year contract, with an option to extend it to 10 years, to support the development of its Nuzyra for the treatment of pulmonary anthrax.
#RAD +22% Rite Aid Corporation - reported better-than-expected Q3 EPS and sales results. The company also issued FY20 EPS guidance above analyst estimates.
#INO +12% Inovio Pharmaceuticals, Inc. -Roth Capital initiated coverage on Inovio Pharmaceuticals with a Buy rating and a $13 price target.
#MOSC +10% Mosaic Acquisition Corp. - Vivint Smart Home and Mosaic Acquisition announced revised transaction terms.
#SNDL +8% Sundial Growers Inc. - after falling 10% on Wednesday. Sundial Growers reported an initiative to enter Canadian medical cannabis business.
#CAG +8% Conagra Brands, Inc. -after the company reported upbeat earnings for its second quarter.
#PING +7% Ping Identity Holding Corp.
#AXSM +7% Axsome Therapeutics, Inc. - priced its 2 million share offering at $87 per share.
#SGEN +6% Seattle Genetics, Inc. - Seattle Genetics and Astellas Pharma said the FDA has granted accelerated approval for Padcev for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a PD-1/L1 inhibitor and a platinum-containing chemotherapy before or after surgery or in a locally advanced or metastatic setting.
#I +5% Intelsat S.A. - after gaining 8% on Wednesday.
#OBSV +5% ObsEva SA
#RUBI +5% the Rubicon Project, Inc. -Rubicon Project and Telaria reported an all stock merger.
#MTCH +4% Match Group, Inc. - announced an agreement with IAC to separate itself from the remaining businesses of IAC.
#MU +4% Micron Technology, Inc.- reported better-than-expected Q1 sales results.
#QIWI +3% Qiwi plc - after dropping 11% on Wednesday.
#AGS +3% PlayAGS, Inc.
#REVG +3% Rev Group Inc - reported better-than-expected Q4 sales results. The company also issued FY20 sales guidance above analyst estimates.
ВНИЗ
#NERV -24% Minerva Neurosciences, Inc. -said the Phase 2b study that evaluated MIN-117 in adult patients with moderate to severe major depressive disorder, or MDD, failed to meet its primary and key secondary endpoints. The company said it has no plans for further clinical development of the molecule in MDD.
#APOG -15% Apogee Enterprises, Inc. - reported worse-than-expected Q3 EPS and sales results. The company also cut FY20 EPS guidance below analyst estimates.
#KODK -14% Eastman Kodak Company -after surging 12% on Wednesday.
#MLHR Herman Miller, Inc. - after the company reported worse-than-expected Q2 sales results. The company also issued Q3 EPS guidance below analyst estimates.
#ASLN -7% ASLAN Pharmaceuticals Limited - after gaining 10% on Wednesday.
#AKRX -6% Akorn, Inc. - after declining 27% on Wednesday.
#XCUR -5% Exicure, Inc. - reported a common stock offering with no size disclosed.
#NIHD -5% NII Holdings, Inc.
#BNTX -5% BioNTech SE -after dropping 5% on Wednesday.
#DRI -4% Darden Restaurants, Inc. - reported second-quarter earnings results.
#YCBD -3% cbdMD, Inc. - reported Q4 results.
💥🇺🇸#VRTX Vertex Pharmaceuticals stock price target raised to $305 from $281 at J.P. Morgan
💥🇺🇸#SGEN Seattle Genetics stock price target raised to $179 from $150 at J.P. Morgan
💥🇺🇸#LRCX Lam Research stock price target raised to $435 from $270 at B. Riley FBR
⚠️🇺🇸#BIIB Biogen stock price target cut to $272 from $293 at J.P. Morgan
💥🇺🇸#PYPD POLYPID STARTED AT OUTPERFORM WITH $23 STOCK PRICE TARGET AT RAYMOND JAMES
💥🇺🇸#EXK ENDEAVOUR SILVER STARTED AT BUY WITH $4.75 STOCK PRICE TARGET AT B. RILEY FBR
⚠️🇺🇸#FNHC FEDNAT DOWNGRADED TO OUTPERFORM FROM STRONG BUY AT RAYMOND JAMES
⚠️🇺🇸#NDAQ NASDAQ DOWNGRADED TO MARKET PERFORM FROM OUTPERFORM AT RAYMOND JAMES
💥🇺🇸#SGEN Seattle Genetics stock price target raised to $179 from $150 at J.P. Morgan
💥🇺🇸#LRCX Lam Research stock price target raised to $435 from $270 at B. Riley FBR
⚠️🇺🇸#BIIB Biogen stock price target cut to $272 from $293 at J.P. Morgan
💥🇺🇸#PYPD POLYPID STARTED AT OUTPERFORM WITH $23 STOCK PRICE TARGET AT RAYMOND JAMES
💥🇺🇸#EXK ENDEAVOUR SILVER STARTED AT BUY WITH $4.75 STOCK PRICE TARGET AT B. RILEY FBR
⚠️🇺🇸#FNHC FEDNAT DOWNGRADED TO OUTPERFORM FROM STRONG BUY AT RAYMOND JAMES
⚠️🇺🇸#NDAQ NASDAQ DOWNGRADED TO MARKET PERFORM FROM OUTPERFORM AT RAYMOND JAMES
🇺🇸#MRK #SGEN #mna
Merck рассматривает возможность покупки биотехнологической компании Seagen. Сумма сделки может составить $28 млрд
Merck рассматривает возможность покупки биотехнологической компании Seagen. Сумма сделки может составить $28 млрд
MarketTwits
🇺🇸#PFE #SGEN #mna Pfizer купит Seagen по $229/акц за $43 млрд. Делает ставку на препараты против рака
MarketTwits
🇺🇸#PFE #SGEN #mna европейский регулятор начал рассмотрение поглощения Seagen компанией Pfizer за $43 млрд